Fox Business
  • Personal Finance
    • Mortgages
    • Student Loans
    • Credit Cards
    • Personal Loans
    • Savings
    • Insurance
    • 401k
    • Retirement
    • Tax Planning
  • Economy
    • Government Spending
    • Money & Policy
    • Small Business
  • Markets
    • Stocks
    • US Markets
    • Cryptocurrency
    • Futures & Commodities
    • Bonds
    • ETFs
    • Business Leaders
    • Industries
    • Retail
    • Pre-Markets
    • Mutual Funds
  • Watchlist
  • Lifestyle
    • Entertainment
    • Rich & Famous
    • Travel
    • Cars
    • Airplanes
    • Food & Drinks
    • Arts
  • Real Estate
    • Personal Real Estate
    • Commercial Real Estate
    • Luxury Properties
  • Tech
    • Digital
    • Social Media
    • Gadgets
    • Business Tech
    • Healthcare Tech
    • Future Tech
    • AI
    • Space
  • Video
  • Podcasts
  • More
Expand / Collapse search
Login
Watch TV
☰
Sports
  • NFL
  • NBA
  • MLB
  • NASCAR
  • Boxing
  • Soccer
  • Golf
  • Tennis
Opinion
Watch Live
  • Fox Business Shows
  • Programming Schedule
  • On Air Personalities
  • Full Episodes
  • Show Clips
  • News Clips
About
  • Channel Finder
  • Jobs
  • Terms of Use
  • Privacy Policy
  • FAQ
  • Media Relations
  • Corporate Information
  • Closed Captioning Policy
  • Accessibility Statement
  • Fox News
  • Fox Nation
  • Fox Business Go
  • Apps & Products
  • Facebook
  • Twitter
  • Instagram
  • YouTube
  • Flipboard
  • LinkedIn
  • RSS
  • Newsletter
  • Spotify
  • iHeartRadio
Fox Business
  • Terms of Use
  • Privacy Policy
  • Your Privacy Choices
  • Help
  • Closed Captioning Policy

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2025 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

Elizabeth Holmes delays prison report date with another appeal
April 26, 2023

Elizabeth Holmes delays prison report date with another appeal

Disgraced Theranos founder Elizabeth Holmes will no longer report to prison to begin serving her 11.25-year sentence after issuing a last-minute appeal.

What Is Ozempic and why is it such a big deal right now?
April 25, 2023

What Is Ozempic and why is it such a big deal right now?

Demand for medications including Ozempic, for weight loss use, led to shortages that sometimes deprived people with diabetes of their prescription refills.

Apple developing AI-powered health coaching service, emotional tracking tools: report
April 25, 2023

Apple developing AI-powered health coaching service, emotional tracking tools: report

Apple is said to be developing a new A.I.-powered health coaching service to motivate users to exercise as well as new tools to track users' emotional health.

Narcan maker aims to make overdose reversal drug more affordable, company says
April 22, 2023

Narcan maker aims to make overdose reversal drug more affordable, company says

Emergent BioSolutions is aiming to make Narcan more affordable after the Food and Drug Administration approved sales of the live-saving without a prescription.

Former Theranos exec Sunny Balwani begins 13-year prison sentence in California
April 21, 2023

Former Theranos exec Sunny Balwani begins 13-year prison sentence in California

Ex-Theranos president Ramesh "Sunny" Balwani, the former top deputy and boyfriend of founder Elizabeth Holmes, has reported to a California prison to begin serving his fraud sentence.

J&J lifts profit forecast as cancer drugs, Stelara buoy pharma unit
April 18, 2023

J&J lifts profit forecast as cancer drugs, Stelara buoy pharma unit

A recovery in medical procedures after being weighed down by hospital staffing shortages helped the medical device unit post sales of $7.48 billion, topping estimates of $7.31 billion.

Merck to acquire Prometheus Biosciences for $10.8B
April 16, 2023

Merck to acquire Prometheus Biosciences for $10.8B

San Diego, California-based Prometheus Biosciences has a drug in development that treats immune diseases including ulcerative colitis and Crohn’s disease.

Mexico frozen strawberry supplier linked to recent Hepatitis A outbreak, identical to 2022 cases: FDA
April 13, 2023

Mexico frozen strawberry supplier linked to recent Hepatitis A outbreak, identical to 2022 cases: FDA

A Mexico-based organic strawberry supplier in Baja California has been linked to a Hepatitis A virus outbreak with a strain identical to an outbreak in 2022.

Former Outcome Health executives found guilty of fraud
April 13, 2023

Former Outcome Health executives found guilty of fraud

A federal jury convicted three former executives of the once-high-flying startup Outcome Health on charges they ran a billion-dollar scheme that defrauded customers.

Medical-device makers gain amid return to normalcy
April 12, 2023

Medical-device makers gain amid return to normalcy

Many of the top large-cap device makers reported relatively rosy fourth-quarter earnings while issuing 2023 guidance that was above analyst expectations.

Medicare beneficiaries would need more than $300,000 for healthcare costs in retirement: EBRI
April 11, 2023

Medicare beneficiaries would need more than $300,000 for healthcare costs in retirement: EBRI

Medicare beneficiaries in retirement would need to have saved anywhere from $96,000 to $383,000 to cover most of their healthcare needs, according to EBRI. The organization found that in general, Medicare Advantage enrollees have lower savings targets. But these private industry plans have their pros and cons.

Elizabeth Holmes loses bid to remain out of prison during appeal
April 11, 2023

Elizabeth Holmes loses bid to remain out of prison during appeal

Disgraced Theranos founder Elizabeth Holmes will report to prison on April 27 after a judge denied her request to remain on house arrest while she appeals her fraud convictions.

Drug companies blast Texas judge for abortion drug decision, call for reversal
April 10, 2023

Drug companies blast Texas judge for abortion drug decision, call for reversal

Hundreds of pharmaceutical firms including Pfizer wrote an open letter condemning a federal judge in Texas who halted the approval of abortion drug mifepristone.

Abortion pill manufacturer Danco Laboratories slams Texas judge's ruling halting FDA approval of mifepristone
April 8, 2023

Abortion pill manufacturer Danco Laboratories slams Texas judge's ruling halting FDA approval of mifepristone

Drug manufacturer Danco Laboratories slammed a decision by a Texas judge to halt FDA approval of their abortion pill Mifeprex (mifepristone), vowing to appeal the decision.

Most US adults oppose Social Security, Medicare cuts, poll shows
April 7, 2023

Most US adults oppose Social Security, Medicare cuts, poll shows

A recent poll found that the majority of American adults are opposed to cutting Medicare or Social Security benefits. More than half are against raising monthly premiums for Medicare.

Johnson & Johnson to pay $8.9B to resolve claims baby powder, talc products caused cancer
April 5, 2023

Johnson & Johnson to pay $8.9B to resolve claims baby powder, talc products caused cancer

Johnson & Johnson said Tuesday that it would pay $8.9 billion to resolve all current and future allegations that its baby powder containing talc caused cancer.

FTC orders Illumina to unwind $7B deal for cancer test developer Grail
April 3, 2023

FTC orders Illumina to unwind $7B deal for cancer test developer Grail

The Federal Trade Commission has rejected Illumina's $7.1 billion acquisition of cancer detection test maker Grail, saying the deal would stifle competition.

Opioid overdose drug Narcan approved for over-the-counter use by FDA
March 29, 2023

Opioid overdose drug Narcan approved for over-the-counter use by FDA

The U.S. Food and Drug Administration announced Wednesday it approved selling the life-saving naloxone-based nasal spray Narcan without a prescription.

Novartis shares jump on breast cancer drug trials success
March 27, 2023

Novartis shares jump on breast cancer drug trials success

Novartis said the drug showed positive topline results from an interim analysis of NATALEE in a broad population of patients with early breast cancer.

Rand Paul slams Moderna CEO on failing to concede to studies on rare heart inflammation due to vaccine
March 22, 2023

Rand Paul slams Moderna CEO on failing to concede to studies on rare heart inflammation due to vaccine

Sen. Rand Paul slammed Moderna CEO Stephane Bancel during a Wednesday Senate hearing over the CEO's rebuking of studies showing negative side effects after receiving the Moderna vaccine.

U.S. Stock Market Quotes

Advertisement
Advertisement
Advertisement
Personal Finance
  • Mortgages
  • Student Loans
  • Credit Cards
  • Personal Loans
  • Savings
  • Insurance
  • 401k
  • Retirement
  • Tax Planning
Economy
  • Government Spending
  • Money & Policy
  • Small Business
Markets
  • Stocks
  • US Markets
  • Cryptocurrency
  • Futures & Commodities
  • Bonds
  • ETFs
  • Business Leaders
  • Industries
  • Retail
  • Pre-Markets
  • Mutual Funds
Watchlist
Lifestyle
  • Entertainment
  • Rich & Famous
  • Travel
  • Cars
  • Airplanes
  • Food & Drinks
  • Arts
Real Estate
  • Personal
  • Commercial
  • Luxury Properties
Tech
  • Digital
  • Social Media
  • Gadgets
  • Business Tech
  • Healthcare Tech
  • Future Tech
  • AI
  • Space
Sports
  • NFL
  • NBA
  • MLB
  • NASCAR
  • Boxing
  • Soccer
  • Golf
  • Tennis
Opinion
Video
About
  • Channel Finder
  • Jobs
  • Terms of Use
  • Privacy Policy
  • FAQ
  • Media Relations
  • Corporate Information
  • Closed Captioning Policy
  • Accessibility Statement
  • Fox News
  • Fox Nation
  • Fox Business Go
  • Apps & Products
  • Facebook
  • Twitter
  • Instagram
  • YouTube
  • Flipboard
  • LinkedIn
  • RSS
  • Newsletter
  • Spotify
  • iHeartRadio
Fox Business
  • Terms of Use
  • Privacy Policy
  • Your Privacy Choices
  • Help
  • Closed Captioning Policy

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2025 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy